文献速递心境障碍儿童青少年精神

跨平台跨物种脂质组学鉴定青少年重性抑郁障碍候选生物标志物

Cross-Platform and cross-species lipidomic profiling identifies promising biomarkers for adolescent major depressive disorder.
PubMed 文献 · Mol Psychiatry · 2026-02-13

该研究整合人类队列与CUMS大鼠模型开展脂质组学分析,训练队列(95例MDD、40例对照)发现244种脂质显著改变,29脂质面板交叉验证准确率90.4%,验证队列8脂质面板准确率71.2%,2脂质组合LPA(18:2)与SPH(d16:1)达72.1%,跨物种证实SPH(d16:1)血清下调一致。

要点

  • 青少年MDD患者存在甘油磷脂、甘油脂和鞘脂代谢改变。
  • SPH(d16:1)在人与大鼠血清中均一致下调,具转化潜力。
  • LPC(0:0/16:0)仅在大鼠前额叶皮层特异性下调。

核心结论

  • 跨平台跨物种脂质组学鉴定出青少年MDD可重复的脂质特征,提示SPH(d16:1)和LPC(0:0/16:0)为转化生物标志物,并涉及甘油磷脂代谢在MDD病理生理中的作用。

研究设计与样本

  • 研究整合人类队列与慢性不可预见温和应激(CUMS)大鼠模型开展脂质组学研究。
  • 训练队列(95例MDD、40例对照)采用靶向UPLC-MS/MS脂质组学分析。
  • 独立验证队列(56例MDD、37例对照)采用非靶向UPLC-HRMS脂质组学分析。
  • 候选标志物通过单变量检验、偏最小二乘判别分析及Boruta、LASSO、RFE三种特征选择方法鉴定,并以交叉验证和外部重复评估预测性能。
  • 通过CUMS大鼠行为学测试及血清和脑组织脂质组学分析考察转化相关性。

主要发现

  • 训练队列中发现244种脂质显著改变,突出甘油磷脂、甘油脂和鞘脂代谢异常。
  • 训练队列中29脂质面板交叉验证准确率达90.4%,精简的7脂质子集达94.8%。
  • 验证队列中8脂质面板准确率达71.2%,最小2脂质组合LPA(18:2)和SPH(d16:1)达72.1%。
  • 跨物种分析证实SPH(d16:1)在人和大鼠血清中均一致下调,LPC(0:0/16:0)仅在大鼠前额叶皮层特异性下调。
  • 回归分析将性别、年龄和焦虑严重程度与脂质改变相关联。

关键数值与推荐

  • 训练队列:29脂质面板交叉验证准确率90.4%,7脂质子集准确率94.8%。
  • 验证队列:8脂质面板准确率71.2%,2脂质组合LPA(18:2)与SPH(d16:1)准确率72.1%。
  • 训练队列中244种脂质显著改变。

临床怎么用

  • SPH(d16:1)和LPC(0:0/16:0)可作为青少年MDD转化生物标志物研究的候选指标。
  • 脂质组学特征有望为青少年MDD的生物标志物引导诊断和治疗提供基础。
  • 性别、年龄和焦虑严重程度与脂质改变相关,临床解读标志物时需考虑这些因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Major depressive disorder (MDD) in adolescents is a critical public health concern, yet objective diagnostic biomarkers remain lacking. We conducted an integrative lipidomics study across human cohorts and a chronic unpredictable mild stress (CUMS) rat model. Targeted UPLC-MS/MS profiling was applied to a training cohort (95 MDD, 40 controls), and untargeted UPLC-HRMS profiling to an independent cohort (56 MDD, 37 controls). Candidate biomarkers were identified using univariate tests, partial least squares discriminant analysis, and three feature-selection methods (Boruta, LASSO, RFE), with predictive performance evaluated by cross-validation and external replication. Translational relevance was examined in CUMS rats through behavioral assays and lipidomic profiling of serum and brain tissues. Pathway enrichment and regression models explored metabolic context and clinical associations. In the training cohort, we found that 244 lipids were significantly altered, highlighting altered glycerophospholipid, glycerolipid, and sphingolipid metabolism. A 29-lipid panel achieved 90.4% cross-validation accuracy, while a reduced 7-lipid subset reached 94.8%. In the validation cohort, an 8-lipid panel achieved 71.2% accuracy, and a minimal 2-lipid set-LPA(18:2) and SPH(d16:1)-reached 72.1%. Cross-species analysis confirmed consistent downregulation of SPH(d16:1) in serum of both humans and rats, and of LPC(0:0/16:0) specifically in the rat prefrontal cortex. Regression analyses linked sex, age, and anxiety severity to lipid alterations. This cross-platform, cross-species study identifies reproducible lipid signatures of adolescent MDD, highlights SPH(d16:1) and LPC(0:0/16:0) as translational biomarkers, and implicates glycerophospholipid metabolism in MDD pathophysiology, providing a foundation for biomarker-guided diagnostics and therapeutics.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gao Y, Dong T, Baranova A, et al. Cross-Platform and cross-species lipidomic profiling identifies promising biomarkers for adolescent major depressive disorder. Mol Psychiatry. 2026. PMID: 41688790. doi:10.1038/s41380-026-03486-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。